Procyon Biopharma develops cancer therapeutics

History:

Procyon Biopharma merged with Cellpep Pharma in 2006 to become Ambrilia Biopharma.

Acquisitions:
Bioxalis Medica (2005)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: